<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01841970</url>
  </required_header>
  <id_info>
    <org_study_id>HET-12-001</org_study_id>
    <nct_id>NCT01841970</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids</brief_title>
  <official_title>Multi-Center, Prospective Study of the Safety and Efficacy of the HET Bipolar System for Treatment of Stage I and Stage II Hemorrhoids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hemorrhoids are vascular cushions in the anal canal. People are normally born with
      hemorrhoids, and the presence of hemorrhoids does not imply disease. However, hemorrhoids
      typically cause symptoms when they enlarge over time. There are two types of hemorrhoids-
      External Hemorrhoids and Internal Hemorrhoids.

      Current minimally invasive technologies for the treatment of internal hemorrhoids are
      associated with several drawbacks that include high rate of recurrence and a need for
      repetitive procedures, frequent post-procedural pain or significant discomfort,
      intra-operative pain and technically demanding. The purpose of this study is to determine
      whether the HET Bipolar System is safe and effective in the treatment of Stage I and Stage II
      hemorrhoids (internal hemorrhoids). The HET Bipolar System is a new alternative device for
      the minimally invasive treatment of Stage I and Stage II hemorrhoids that incorporate design
      features with the intent of resolving each of the major limitations of currently available
      technology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, the investigators will use the HET Bipolar System for the treatment of Stage I
      and Stage II hemorrhoids, where significant tissue prolapse is not present. The hemorrhoids
      are treated by bipolar ligation of the superior hemorrhoidal blood supply.

      Each prospective subject will be screened for inclusion and exclusion criteria at least one
      week prior to treatment. All patients undergoing treatment will review and sign the study
      Informed Consent prior to their procedure.

      One to three internal hemorrhoids will be treated in one therapeutic session. The number will
      be based on the investigator's judgment of which quadrants are symptomatic. Evaluations will
      be recorded for all treated subjects immediately following treatment. Subjects will be
      followed at 1, 3, and 6 months post procedure unless complications are reported between
      scheduled follow-up dates. At each post treatment follow-up, a report will be made of
      pain/discomfort, bleeding, medication use, itching, presence of adverse events or
      complications and need for supplemental treatment. Face-to-face follow-up evaluations will
      include anoscopic evaluation and assessment of hemorrhoid and other relevant symptoms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Resolution of Symptoms</measure>
    <time_frame>Post treatment at Month1, Month 3, Month 6</time_frame>
    <description>The primary endpoint analysis was the resolution of symptoms, including resolution of bleeding and prolapse, if present prior to treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Recurrence of Pre-procedure Symptoms</measure>
    <time_frame>Post treatment at Month 1, Month 3, and Month 6</time_frame>
    <description>Recurrence of pre-procedure symptoms after initial improvement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence of Symptoms That Had Resolved With Treatment</measure>
    <time_frame>Post treatment at Month 1, Month 3, Month 6</time_frame>
    <description>Number of patients with recurrence of symptoms defined as external thrombosed hemorrhoids, infection, mucous discharge, new fissure, stenosis and delayed healing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Recorded Yes or No on Visual Analog Scale (VAS)</measure>
    <time_frame>Post treatment at Month 1, Month 3, Month 6</time_frame>
    <description>Patient reported pain on 10 point scale where 0 =No Pain and &gt; 0 = Pain with 10 being the worst.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Pain Score Based on the Visual Analog Pain Scale</measure>
    <time_frame>Post treatment at Month 1, Month 3, Month 6</time_frame>
    <description>Mean pain score based on the Visual Analog pain scale. Patient reported pain on 10 point scale where 0 =No Pain and &gt; 0 = Pain with 10 being the worst.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Hemorrhoids, Internal</condition>
  <arm_group>
    <arm_group_label>HET Arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Active arm. A single procedure with HET was used to treat Grade I and Grade II hemorrhoids</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HET Bipolar System</intervention_name>
    <description>The HET Bipolar System is used to treat hemorrhoids by bipolar ligation of the superior hemorrhoidal blood supply.</description>
    <arm_group_label>HET Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject over 21 years of age

          -  General good health

          -  Subject undergoing elective treatment for Stage I or Stage II internal hemorrhoids

          -  Chronic bleeding from Stage I or Stage II internal hemorrhoids (at least weekly
             occurrence

          -  Failure of prior medical management

        Exclusion Criteria:

          -  Under 21 years of age.

          -  Gastrointestinal bleeding from source other than their internal hemorrhoids

          -  Active proctitis

          -  Inflammatory bowel disease

          -  HIV positive or immunocompromised

          -  Rectal wall prolapse

          -  Stage III and Stage IV hemorrhoids

          -  Medical conditions requiring anticoagulants and/or subject to receive anticoagulants
             within 7 days of initial examination

          -  Pregnancy

          -  Rectal malignancy

          -  Hepatitis C

          -  Liver cirrhosis

          -  End stage renal disease

          -  Receiving chemotherapy

          -  Advanced malignancy

          -  Documented bleeding diathesis

          -  Treatment with an investigational drug or medical device in the past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2013</study_first_submitted>
  <study_first_submitted_qc>April 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2013</study_first_posted>
  <results_first_submitted>May 6, 2016</results_first_submitted>
  <results_first_submitted_qc>November 17, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 16, 2017</results_first_posted>
  <last_update_submitted>November 17, 2016</last_update_submitted>
  <last_update_submitted_qc>November 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>HET Arm</title>
          <description>All subjects enrolled into the study were treated with the HET Bipolar System</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>HET Arm</title>
          <description>Active arm. A single procedure with HET was used to treat Grade I and Grade II hemorrhoids
HET Bipolar System: The HET Bipolar System is used to treat hemorrhoids by bipolar ligation of the superior hemorrhoidal blood supply.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.6" spread="18.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hemorrhoid grade</title>
          <description>Hemorrhoids as graded on a scale of I-IV, with I being least symptomatic. Grade I: Bleeding hemorrhoids which do not prolapse outside the anal canal â€¢ Grade II: Hemorrhoids which prolapse, usually with defecation, but retract spontaneously</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Grade I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Grade II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pain (Y/N)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Pain Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Bleeding (Y/N)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Bleeding Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bleeding No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Treatment Received (Y/N)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Previous Treatment Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Previous Treatment No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Resolution of Symptoms</title>
        <description>The primary endpoint analysis was the resolution of symptoms, including resolution of bleeding and prolapse, if present prior to treatment</description>
        <time_frame>Post treatment at Month1, Month 3, Month 6</time_frame>
        <population>18 participants included. 2 participants were lost to follow up.</population>
        <group_list>
          <group group_id="O1">
            <title>HET Arm</title>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Resolution of Symptoms</title>
          <description>The primary endpoint analysis was the resolution of symptoms, including resolution of bleeding and prolapse, if present prior to treatment</description>
          <population>18 participants included. 2 participants were lost to follow up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Recurrence of Pre-procedure Symptoms</title>
        <description>Recurrence of pre-procedure symptoms after initial improvement</description>
        <time_frame>Post treatment at Month 1, Month 3, and Month 6</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Month 1</title>
          </group>
          <group group_id="O2">
            <title>Month 3</title>
          </group>
          <group group_id="O3">
            <title>Month 6</title>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Recurrence of Pre-procedure Symptoms</title>
          <description>Recurrence of pre-procedure symptoms after initial improvement</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recurrence Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Recurrence No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recurrence of Symptoms That Had Resolved With Treatment</title>
        <description>Number of patients with recurrence of symptoms defined as external thrombosed hemorrhoids, infection, mucous discharge, new fissure, stenosis and delayed healing.</description>
        <time_frame>Post treatment at Month 1, Month 3, Month 6</time_frame>
        <population>At Month 1, 3 and 6 the number of participants include patients followed through that time period. The remaining patients were lost to follow up.</population>
        <group_list>
          <group group_id="O1">
            <title>Month 1</title>
          </group>
          <group group_id="O2">
            <title>Month 3</title>
          </group>
          <group group_id="O3">
            <title>Month 6</title>
          </group>
        </group_list>
        <measure>
          <title>Recurrence of Symptoms That Had Resolved With Treatment</title>
          <description>Number of patients with recurrence of symptoms defined as external thrombosed hemorrhoids, infection, mucous discharge, new fissure, stenosis and delayed healing.</description>
          <population>At Month 1, 3 and 6 the number of participants include patients followed through that time period. The remaining patients were lost to follow up.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>External Thrombosed Hemorrhoids - NO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>External Thrombosed Hemorrhoids - YES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Signs of Infection YES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Signs of Infection NO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mucous Discharge YES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mucous Discharge NO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Fissure YES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>New Fissure NO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Delayed Healing YES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Delayed Healing NO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stenosis YES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stenosis NO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Conditions YES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other Conditions No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain Recorded Yes or No on Visual Analog Scale (VAS)</title>
        <description>Patient reported pain on 10 point scale where 0 =No Pain and &gt; 0 = Pain with 10 being the worst.</description>
        <time_frame>Post treatment at Month 1, Month 3, Month 6</time_frame>
        <population>At Month 1, 3 and 6 the number of participants include patients followed through that time period. The remaining patients were lost to follow up.</population>
        <group_list>
          <group group_id="O1">
            <title>Month 1</title>
          </group>
          <group group_id="O2">
            <title>Month 3</title>
          </group>
          <group group_id="O3">
            <title>Month 6</title>
          </group>
        </group_list>
        <measure>
          <title>Pain Recorded Yes or No on Visual Analog Scale (VAS)</title>
          <description>Patient reported pain on 10 point scale where 0 =No Pain and &gt; 0 = Pain with 10 being the worst.</description>
          <population>At Month 1, 3 and 6 the number of participants include patients followed through that time period. The remaining patients were lost to follow up.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain YES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pain NO</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Pain Score Based on the Visual Analog Pain Scale</title>
        <description>Mean pain score based on the Visual Analog pain scale. Patient reported pain on 10 point scale where 0 =No Pain and &gt; 0 = Pain with 10 being the worst.</description>
        <time_frame>Post treatment at Month 1, Month 3, Month 6</time_frame>
        <population>At Month 1, 3 and 6 the number of participants include patients followed through that time period. The remaining patients were lost to follow up.</population>
        <group_list>
          <group group_id="O1">
            <title>Month 1</title>
          </group>
          <group group_id="O2">
            <title>Month 3</title>
          </group>
          <group group_id="O3">
            <title>Month 6</title>
          </group>
        </group_list>
        <measure>
          <title>Mean Pain Score Based on the Visual Analog Pain Scale</title>
          <description>Mean pain score based on the Visual Analog pain scale. Patient reported pain on 10 point scale where 0 =No Pain and &gt; 0 = Pain with 10 being the worst.</description>
          <population>At Month 1, 3 and 6 the number of participants include patients followed through that time period. The remaining patients were lost to follow up.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="18"/>
                <count group_id="O2" value="11"/>
                <count group_id="O3" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7" spread="1.57"/>
                    <measurement group_id="O2" value="0.4" spread="1.21"/>
                    <measurement group_id="O3" value="0.1" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>HET Arm</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>internal engorged hemorrhoids</sub_title>
                <description>The event was assessed as not related to the device, and was considered to be a recurrence of the study disease.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>urgency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>skin tags</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bleeding/Refractory Bleeding</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Gas/Gas Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Intermittent Burning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Internal Engorged Hemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>New Fissure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Pruritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Recurrence</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Skin Tags</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Thrombosed Hemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Urgency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director, Clinical Research</name_or_title>
      <organization>Medtronic Surgical Innovations</organization>
      <phone>508-452-4028</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

